5TH ANNUAL PHARMACEUTICAL LEADERSHIP SUMMIT & BUSINESS LEADERSHIP AWARDS 2012

Pharmaleaders Magazine, India’s first opinion based & research driven bi-monthly magazine has finished two memorable glorious years of its relentless reporting in Pharma Journalism in a unbiased, fearless & independent way. Over the last two year, The Magazine has covered some of the biggest voices in healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry to the statutory Authorities like Ministry of Health & Family Affairs, Dept of Chemicals & Fertilizers, DCGA, FDA & many other institutions to present the pressing demands of the healthcare industry. Pharmaleaders Magazine has also presented our healthcare industry to the global platforms being the largest research based & technologically innovative hub of Healthcare Companies. Pharmaleaders Magazine  since last one decade has been  organizing world-class “Pharmaceutical Leadership Summit & Excellence Awards” year after year to create a platform for knowledge sharing & dissemination of innovative ideas from the stalwarts of the Industry. Pharmaleaders is all set to bring together some of the biggest names in healthcare, pharmaceutical circle, policy makers to create a platform of interaction of a very intense debate on Brand India : Beyond Generics, Growth, Challenges & Developments in Mumbai on Friday, the 21st September 2012 at Hotel Hilton Mumbai International Airport. The timing of such a Summit is viewed as very crucial at a time, the Government of India announcing the landmark historical decision to make medicines available to the needy in the form of Generics. In fact, India has put in place a $5.4 billion policy to provide free medicine to its people, a decision that could change the lives of hundreds of millions, but a ban on branded drugs stands to cut Big Pharma out of the windfall. Many Industry Experts question the implementation of such a policy at a time when the nation is affected by diverse factors such as weak government due to coalition politics, corrupt administration & unstable economic conditions. While the nation will stand to get benefited from such a grand plan, there will be every question mark on the successful implementation of free for medicine plans says Satya Brahma, Editor-In-Chief of Pharmaleaders, “ It indeed will open up a divide of interests between the domestic pharma majors & Big Pharma as some of the best known brands will go for a toss, something major MNC’s cant afford, moreover, patient safety will be a biggest challenge Satya added. Organised by Pharmaleaders in association with several leading trade & Pressure bodies, 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 (www.asiapharmaleaders.com   ) will spring some controversial thoughts by the veterans of the Industry.


      

BRAND INDIA : BEYOND GENERICS

The much awaited leadership event of Pharmaleaders’s Annual meet, 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 has an aptly theme “Brand India”, Beyond Generics - Growth, Challenges & Opportunities to be staged in India’s leading capital of Pharmaceutical Companies, Mumbai. Widely perceived by Industry’s Opinion Leaders & Analysts as the Centre-Point of debating complex & serious issues, the platform will showcase more than 20 Industry Leaders deliberating on crucial topics of great significance. More than 200 CEO’s, Owners of Pharmaceutical Companies, Pharma Academia, Policy Makers, Management Firms, Diplomats along with overseas Companies have blocked their date to attend at the commercial capital of India in Mumbai on Friday, 21st September at Hotel Hilton Mumbai International Airport, India. I feel “While the earlier Summits since last four years debated equally significant Issues , This year’s Debate will assume significance in view of Indian Government’s announcement to provide free medicines & push for Generics, a decision that may reshuffle the business models of both domestic & MNC”s as Branded Medicines will take a beating”.

Entering in its 5th year, The Annual Pharmaceutical Leadership Summit & Awards 2012 has a glorious track record of bringing together some of the finest think-tanks of the different spectrums of the healthcare Industry, Pharma Academia, Bureaucrats, Policy makers & Social Entrepreneurs. Since its inception, Pharmaceutical Leadership Summit & Awards, has witnessed more than 2000 delegates, over 200 veteran Speakers & more than 150 top notch companies & Entrepreneurs have been recognized, felicitated & awarded by this platform. Known for debating complex issues, controversial topics & regulatory hurdles confronted by the industry in its past Annual Meets, the 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 will debate on Brand India Pharma in line with the Indian Government’s objective & vision to project Indian Pharma Industry in the global map. Announcing the Event, I am sure “Like in the past, we attempt to create a vibrant platform of interaction amongst the professionals of the Industry. With the Government of India’s game changing they to move ahead with ambitious plans to spend nearly $A5 billion to supply free drugs to patients - bringing the country closer to universal health coverage, the 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 will be the ultimate destination for a serious debate on Brand India”. 5th Annual Pharmaceutical Leadership Summit will also felicitate Business Leadership Awards to top performers in 30 categories who will be put under voting for the next two months, Satya added.

The Challenge

India is emerging out to be the biggest super-power in pharmaceuticals & healthcare as we move forward bringing out break-through technologies & latest innovations in the areas of research. The World Market is certainly upbeat investing their time, energy & money in the Indian healthcare market as India continue to demonstrate consistent performances. The Indian pharmaceutical industry is responsible for around 10% of world pharmaceutical production. Indian pharmaceutical and healthcare industry took a quantum leap and with a scorching pace grew from US$ 11.4 billion in 2010 to US$ 13 billion in 2012 & the real challenge will be USD 55 Billion mark by 2020 as revealed by the IMS Prognosis Report 2011. The Indian pharmaceutical market is expected to touch US$74 billion sales by 2020 from US$11 billion now. India's pharmaceutical market grew at 15.7% during December 2011, with growth in key therapy areas, including anti-diabetics, derma and vitamins outperforming the market. India has every chance to capitalize the opportunity to become a pharmaceutical superpower in 2020 and a hub for all pharmaceutical manufacturing and research needs.  The 5th Annual India Leadership Conclave & Business Leadership Awards 2012 will be attended by more than 200 CEO’s of the Industry with participation from overseas countries. The Event will be debated by some of the leading stalwarts & icons of the Healthcare Industry.  Considering the life cycle of block-buster molecules having an average of 20 odd years & in an age where billions of dollars are being spent on research for new molecules and drugs, the best Brands are the old Brands that has topped the list. While top 10 Brands in India come from the mix of Domestic Pharma majors & MNC’s, the big debate of Generics, to my mind will not go well with the medical profession as Doctors will not be aware the manufacturers details as many will plunge into it. While, domestic players dominate the rankings with a 65% share by owning 196 brands in the top-300 list. However, despite a limited presence in India (20% of the total domestic sales), MNCs have demonstrated better brand building capabilities and have created 92 of the top-300 brands, and five of top 10 brands sold in the country. It is pertinent here to note that India has the highest number of US-FDA approved plants outside the US. Most of these plants have multiple approvals from regulatory authorities in Canada, Australia and Germany. India also holds a strong position in producing generic drugs through reverse engineering.

I take this opportunity to be a part of this platform & come & share your thoughts with the leaders of Indian Healthcare Industry.

Satya Brahma

Chairman – Organizing Committee, 5th Annual Pharmaceutical Leadership Summit & Business Leadership awards 2012.  Chairman & Editor –in-Chief - Pharmaleaders

Share this post



Add this page to your favorite Social Bookmarking websites
Reddit! Del.icio.us! Mixx! Free and Open Source Software News Google! Live! Facebook! StumbleUpon! TwitThis Joomla Free PHP
You need Flash player 6+ and JavaScript enabled to view this video.

Speakers

Mr S V Veerramani.jpgDr Rashmi Shetty.jpgDr Mahesh Burande.jpgDr Mukesh Hariawala.jpgDr Kannan Vishwanath.jpgDr B R ShettY.jpgDr Shenaz Khaliz.jpgShivkumar Kunchithapatham.jpgSatya Brahma.jpgDr Rajaram Samant.jpgDr Mukesh Batra.jpgRanjit Shahani.jpgKewal Handa.jpgDr Shuba Dharmana.jpgDr Sailesh Iyenger.jpgFrancois Liccope.jpgDr Hasit Jaspuria.jpg
 
bulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbulletbullet
spinner

free counters

Youtube

Partners

Partners_logo

LeamonWebHosting_Ashish Agarwal


Twitter

Who's Online

We have 8 guests online
Members : 4015
Content : 13
Web Links : 6
Content View Hits : 95276

Guest's IP

You are connecting to this site from: 54.166.120.175